Variant report
Variant | esv3340605 |
---|---|
Chromosome Location | chr11:72356804-72361102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr11:72357616-72357742 | K562 | blood: | n/a | n/a |
2 | CTCF | chr11:72356759-72356829 | Hela-S3 | cervix: | n/a | chr11:72356773-72356794 chr11:72356780-72356793 chr11:72356778-72356796 |
3 | CTCF | chr11:72356680-72356830 | GM06990 | blood: | n/a | chr11:72356773-72356794 chr11:72356780-72356793 chr11:72356778-72356796 |
4 | CTCF | chr11:72357520-72357670 | GM06990 | blood: | n/a | n/a |
5 | JUND | chr11:72357152-72357389 | H1-hESC | embryonic stem cell: | n/a | chr11:72357265-72357273 chr11:72357264-72357274 chr11:72357264-72357274 chr11:72357264-72357274 |
6 | JUND | chr11:72357114-72357348 | H1-hESC | embryonic stem cell: | n/a | chr11:72357265-72357273 chr11:72357264-72357274 chr11:72357264-72357274 chr11:72357264-72357274 |
7 | MAX | chr11:72357546-72357811 | K562 | blood: | n/a | n/a |
8 | MAX | chr11:72358958-72359153 | H1-hESC | embryonic stem cell: | n/a | chr11:72359139-72359150 chr11:72359142-72359149 |
9 | MAX | chr11:72359899-72359953 | NB4 | blood: | n/a | chr11:72359938-72359948 |
10 | MAZ | chr11:72359345-72359359 | Hela-S3 | cervix: | n/a | n/a |
11 | MYC | chr11:72359882-72359916 | GM12878 | blood: | n/a | n/a |
12 | POLR2A | chr11:72360359-72360401 | HUVEC | blood vessel: | n/a | n/a |
13 | POLR2A | chr11:72360664-72361036 | H1-neurons | neurons: | n/a | n/a |
14 | USF1 | chr11:72357588-72357843 | K562 | blood: | n/a | n/a |
15 | USF2 | chr11:72357669-72357673 | HepG2 | liver: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:72352591..72354863-chr11:72359985..72362925,3 | MCF-7 | breast: | |
2 | chr11:72357248..72359337-chr11:72359390..72360915,2 | MCF-7 | breast: | |
3 | chr11:72356436..72357104-chr2:117515929..117516830,2 | MCF-7 | breast: | |
4 | chr11:72357248..72359337-chr11:72359390..72360915,2 | MCF-7 | breast: | |
5 | chr11:72351375..72354912-chr11:72357807..72359831,3 | K562 | blood: | |
6 | chr11:72354924..72356941-chr11:72362580..72364598,3 | K562 | blood: | |
7 | chr11:72356337..72359117-chr11:72532561..72534508,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ATG16L2-4 | chr11:72360294-72360382 | ENSG00000255808.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
PDE2A | TF binding region |
ENSG00000255808 | chromatin interactions |
ENSG00000186642 | chromatin interactions |
ENSG00000168010 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34659576 | chr11:72356809-72356810 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs370551531 | chr11:72356826-72356827 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs188221693 | chr11:72356845-72356846 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs117081755 | chr11:72356846-72356847 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs79456357 | chr11:72356878-72356879 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs552204435 | chr11:72356884-72356885 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs78620466 | chr11:72356942-72356943 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs191864674 | chr11:72356947-72356948 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs184251843 | chr11:72356967-72356968 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs189422100 | chr11:72356969-72356970 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs565279562 | chr11:72357009-72357010 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs149607351 | chr11:72357059-72357060 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs544605375 | chr11:72357080-72357081 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs562609417 | chr11:72357095-72357096 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs540457728 | chr11:72357115-72357116 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs144294269 | chr11:72357140-72357141 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs547963856 | chr11:72357185-72357186 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs71477740 | chr11:72357192-72357193 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs559953644 | chr11:72357221-72357222 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs115441144 | chr11:72357238-72357239 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs181998835 | chr11:72357278-72357279 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs185166572 | chr11:72357288-72357289 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs570535591 | chr11:72357343-72357344 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs370193636 | chr11:72357350-72357351 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs537408231 | chr11:72357356-72357357 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs549769156 | chr11:72357361-72357362 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs569548913 | chr11:72357412-72357413 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs536981088 | chr11:72357428-72357429 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs534826929 | chr11:72357438-72357439 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs553912606 | chr11:72357481-72357482 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs573525924 | chr11:72357484-72357485 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs534409256 | chr11:72357535-72357536 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs558743688 | chr11:72357593-72357594 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs148333296 | chr11:72357698-72357699 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs544254939 | chr11:72357784-72357785 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs568476755 | chr11:72357806-72357807 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs574378384 | chr11:72357822-72357823 | Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs541765360 | chr11:72357858-72357859 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs560017575 | chr11:72357871-72357872 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs527441800 | chr11:72357942-72357943 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs376185557 | chr11:72357986-72357987 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs60431679 | chr11:72358001-72358002 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs554330645 | chr11:72358076-72358077 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs563997397 | chr11:72358087-72358088 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs372583881 | chr11:72358124-72358125 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs531463354 | chr11:72358169-72358170 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs549496217 | chr11:72358241-72358242 | Bivalent Enhancer Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs536516028 | chr11:72358304-72358305 | Bivalent Enhancer Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs568103221 | chr11:72358305-72358306 | Bivalent Enhancer Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs574518334 | chr11:72358306-72358307 | Bivalent Enhancer Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 19153074 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:72354200-72359600 | Weak transcription | Fetal Heart | heart |
2 | chr11:72354600-72361200 | Weak transcription | Gastric | stomach |
3 | chr11:72354600-72365000 | Weak transcription | Brain Cingulate Gyrus | brain |
4 | chr11:72354800-72359600 | Weak transcription | Brain Anterior Caudate | brain |
5 | chr11:72355000-72360600 | Weak transcription | Fetal Brain Male | brain |
6 | chr11:72355000-72362000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr11:72355000-72363800 | Weak transcription | Fetal Brain Female | brain |
8 | chr11:72357000-72357800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr11:72358200-72358400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr11:72359200-72359400 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
11 | chr11:72359400-72359600 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
12 | chr11:72359400-72361000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr11:72359600-72360400 | Enhancers | Fetal Heart | heart |
14 | chr11:72359600-72360800 | Enhancers | Brain Anterior Caudate | brain |
15 | chr11:72359800-72360000 | Bivalent Enhancer | Fetal Stomach | stomach |
16 | chr11:72360400-72360600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr11:72360400-72360600 | Enhancers | Fetal Muscle Trunk | muscle |
18 | chr11:72360600-72360800 | Enhancers | Fetal Brain Male | brain |
19 | chr11:72360800-72361200 | Weak transcription | Fetal Brain Male | brain |
20 | chr11:72360800-72363400 | Weak transcription | Brain Anterior Caudate | brain |